Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And Approve The Un-Audited Financial Results For The Quarter Ending 30Th June 2021

 BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 05th August 2021 online through video conferencing, to inter alia consider and adopt un-audited financial results for the first quarter ending 30th June 2021 and any other business with the permission of the Chair. Further in accordance with the Code of Conduct for prevention of Insider Trading pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in securities of the Company shall remain closed until 48 hours after the financial results approved at the meeting are made public.
27-07-2021
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Discrepancies In Standalone Financial Results

 We acknowledge the receipt of your email dated 17th July 2021 and our reply is as follow: Discrepancy: In PDF of Cash Flow Statement - Closing Balance of Cash & Cash Equivalent Not Tallying.(Confirm Net Increase/ [Decrease] In Cash or cash Equivalents Figure is Positive & Negative).Kindly File Rectified Figures of Cash Flow Statement. Company's Reply Revised Cash Flow Statement is attached herewith.
26-07-2021
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Book Closure For The Purpose Of Annual General Meeting

 We would like to inform you that, further to our announcement dated 25th June 2021 the Company's register of members will be closed from 07th August 2021 to 14th August 2021 (both days inclusive) for the purpose of annual general meeting. Security Code Type of security and paid up value Book closure Record date Purpose From to 532989 (BSE) BAFNAPH(NSE) Equity shares Rs.10/- paid up 07th August 2021 (Saturday) 14th August 2021 (Saturday) Both day inclusive N.A Annual General Meeting scheduled to be held on 14th August 2021
26-07-2021
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Book Closure For The Purpose Of Annual General Meeting

 We would like to inform you that, further to our announcement dated 25th June 2021 the Company's register of members will be closed from 07th August 2021 to 14th August 2021 (both days inclusive) for the purpose of annual general meeting. Security Code Type of security and paid up value Book closure Record date Purpose From to 532989 (BSE) BAFNAPH(NSE) Equity shares Rs.10/- paid up 07th August 2021 (Saturday) 14th August 2021 (Saturday) Both day inclusive N.A Annual General Meeting scheduled to be held on 14th August 2021
26-07-2021
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2020-21 along with Notice of Annual General Meeting, which is being sent in electronic mode to the Shareholders of the Company. The said Annual Report 2020-21 has also been updated on the Company's website at www.bafnapharma.com.
22-07-2021
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholding for the Period Ended June 30, 2021

 Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
20-07-2021
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Statement Of Investor Complaints For The Quarter Ended June 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Jitendra Kumar PalDesignation :- Company Secretary and Compliance Officer
14-07-2021
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Details Of Related Party Transactions

 Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith the disclosure of related party transactions for the half-year ended March 31, 2021. This is for your information and record.
09-07-2021
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Please find enclosed Secretarial Compliance Report of the Company under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 issued by M/s. A.K.Jain & Associates, Company Secretaries, Secretarial Auditor of the Company for the year ending 31st March 2021.
30-06-2021
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Outcome of Board Meeting (AGM on August 14, 2021)

 Bafna Pharmaceuticals Ltd has informed BSE regarding Outcome of Board Meeting held on June 25, 2021.
25-06-2021
Next Page
Close

Let's Open Free Demat Account